NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
Vici Health Sciences, LLC has applied to the Drug Enforcement Administration to register as an importer of basic classes of controlled substances.
The application was published on 25 August 2026 and concerns Vici Health Sciences, LLC becoming a registered importer of basic classes of controlled substances. Public comments are open until 24 September 2026.
Biopharmaceutical Research Company applied to register as a bulk manufacturer of basic classes of controlled substances.
The Drug Enforcement Administration published the application on 25 August 2026. Public comments are open until 26 October 2026.
Weekly Psychedelic Policy Briefing: August 23, 2026
Oregon's psilocybin program posted its first real-world outcome data this week, just as regulators move on fee increases that operators say could close the market. Plus Trump's FDA nominee and Johnson & Johnson's bet ...
What’s stopping psychedelic therapy in China? 5 Questions with medical ethicist Jennifer Docherty
Docherty discusses her interviews about psychedelic end-of-life care with clinicians in Hong Kong.
MDMA and the FDA, Take Two
PLUS the Psychedelic Seeker's Guide, the World Ayahuasca Forum, and the best films to get trippy to. [...] Read More... The post MDMA and the FDA, Take Two appeared first on DoubleBlind Mag.
SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
U.S. publication of a patent application covering the MDMA-N-acylethanolamines combination expands intellectual property generated through the collaboration, and provides guidance addressing clinical…
KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury (NCT07563296, ketamine)
This Phase II, single-group trial (n=12) will assess the safety and tolerability of ketamine-assisted psychotherapy (KAP) in adults aged 18 to 65 years with burn injuries and acute stress symptoms. Participants will r...
Global Altered States: Anytown, USA
This Week's Sunday Insider, Global Altered States: The Psychedelic Revolution is smaller than it looks.
Psychedelic raves act as a modern rite of passage with complex psychological effects, new research suggests
A new study reveals that for Israeli rave-goers using psychedelics, the party is just one phase. Extensive preparations and complex physical, emotional, and social after-effects show the experience extends well beyond...
Distinct response of resting-state brain networks to psilocybin in autism
This double-blind, pseudo-randomised crossover brain imaging study (n=67) compared autistic and non-autistic adults after single doses of psilocybin (2 or 5 mg) or placebo. The 5 mg dose altered resting-state brain-ne...
Distinct response of resting-state brain networks to psilocybin in autism
This double-blind, pseudo-randomised crossover brain imaging study (n=67) compared autistic and non-autistic adults after single doses of psilocybin (2 or 5 mg) or placebo. The 5 mg dose altered resting-state brain-ne...
Psychedelic Policy Briefing 8.21.26
Resilient Pharmaceuticals (formerly Lykos Therapeutics and MAPS PBC), reportedly resubmitted their once-rejected New Drug Application (NDA) for MDMA-assisted therapy for PTSD to the FDA, triggering a fresh review cycl...
August 2026 Newsletter
Burning Man is close. Since 2012, anyone having a challenging experience on playa… The post August 2026 Newsletter appeared first on Zendo Project.
Quantum Biopharma Provides Corporate Update
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, July 07, 2026…